Clinical trial

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

NCT01794143

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Sulfonylurea (glimepiride) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention DPP-4 inhibitor (sitagliptin) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention GLP-1 receptor agonist (liraglutide) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Insulin (glargine) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-05-01

PhasePHASE3

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Comparative Effectiveness of Glycemia-lowering Medicationsunresolved

Interventions

Sulfonylurea (glimepiride)DRUG

DPP-4 inhibitor (sitagliptin)DRUG

GLP-1 receptor agonist (liraglutide)DRUG

Insulin (glargine)DRUG

Sponsors & collaborators

GRADE Study Grouplead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Centers for Disease Control and Preventioncollaborator

Mapped research locations

New YorkNew York, United States2 DallasTexas, United States2 PortlandOregon, United States2 DurhamNorth Carolina, United States2 MinneapolisMinnesota, United States2 HoustonTexas, United States1 BostonMassachusetts, United States1 St LouisMissouri, United States1 MiamiFlorida, United States1 San AntonioTexas, United States1 NashvilleTennessee, United States1 SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01794143 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.